BECONASEAQ (GlaxoSmithKline LLC)


Welcome to the PulseAid listing for the BECONASE drug offered from GlaxoSmithKline LLC. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: GlaxoSmithKline LLC
NON-PROPRIETARY NAME: beclomethasone dipropionate monohydrate
SUBSTANCE NAME: BECLOMETHASONE DIPROPIONATE MONOHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
ROUTE: NASAL
DOSAGE FORM: SPRAY, SUSPENSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1989-10-01
END MARKETING DATE: 0000-00-00


BECONASE AQ HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBECONASE AQ from GlaxoSmithKline LLC
LABELER NAME: GlaxoSmithKline LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 42(ug/1)
START MARKETING DATE: 1989-10-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0173-0388_17600f11-d034-4c3d-974f-8287b42db37a
PRODUCT NDC: 0173-0388
APPLICATION NUMBER: NDA019389

Other BECLOMETHASONE DIPROPIONATE MONOHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GlaxoSmithKline LLCBECONASE
Stat Rx USA LLCBECONASE